COVID-19 Vaccination Recommendations for Children
Sean O’Leary, who leads the AAP Committee on Infectious Diseases (COID), pointed out that the pandemic landscape has shifted significantly compared to four or five years ago, particularly for healthy older kids. However, he noted that the risk of hospitalization remains high for younger children and those with certain health conditions.
CDC data indicates that children under 2 have the highest COVID-19 hospitalization rates among pediatric groups. Alarmingly, the hospitalization rates for kids aged 6 months to 23 months are on par with those of adults aged 50 to 64. Importantly, over half of the children in that age group who are hospitalized for COVID-19 do not have underlying conditions that could heighten their risk for severe illness.
For children aged 2 to 18, the AAP advises COVID-19 vaccinations for those with medical conditions that elevate their risk, residents of care facilities, and those who have never received a vaccine or live with high-risk individuals. Additionally, the AAP emphasizes that all other children and teens should have the option to receive updated seasonal vaccines if they wish.
Kressly mentioned that the AAP will keep offering vaccine recommendations based on scientific evidence to ensure the health of infants, children, and adolescents. Pediatricians recognize the crucial role of routine immunizations in maintaining the well-being of children, families, and communities.
Insurance Coverage Challenges
As schools reopen and COVID-19 cases rise, along with the impending cold-weather respiratory virus season, concerns arise regarding how insurance companies will interpret the differing recommendations. While insurers are mandated to cover vaccines recommended by the CDC, they aren’t required to follow medical group suggestions.
The AAP has been engaging with insurers to advocate for coverage of evidence-based vaccine recommendations.
O’Leary remarked that insurers seem dedicated to supporting these recommendations. Additionally, a statement from AHIP, the major insurance lobby, indicated in June that its members are committed to ongoing vaccine coverage to ensure access and affordability during this respiratory virus season.
